Ubs Asset Management Americas Inc Iovance Biotherapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,946,842 shares of IOVA stock, worth $12.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,946,842
Previous 1,994,500
2.39%
Holding current value
$12.5 Million
Previous $16 Million
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding IOVA
# of Institutions
312Shares Held
237MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$175 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$170 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$154 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$136 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$84.5 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.01B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...